Literature DB >> 22981768

Intake of a resveratrol-containing dietary supplement has no impact on DNA stability in healthy subjects.

A Heger1, F Ferk, A Nersesyan, T Szekeres, M Kundi, K H Wagner, G Haidinger, M Mišík, S Knasmüller.   

Abstract

It has been postulated that the beneficial health effects of dietary supplements and of red wines which contain resveratrol (RES) are due to the anti-oxidative properties of this phenolic compound, but evidence for protection against reactive oxygen species is mainly based on results of in vitro experiments and high-dose animal experiments. Aim of this study was to find out if intake of a RES-containing supplement protects healthy humans against oxidative DNA-damage and alters their redox status. Therefore, an intervention trial was conducted in which the participants (n=12) consumed a RES-containing supplement over a period of five days. At the start, after one day and after five days of consumption, and after a washout period DNA stability was measured in single cell gel electrophoresis (SCGE) assays with peripheral blood lymphocytes. These tests were conducted (a) under standard conditions, which reflect single- and double-strand DNA breaks, (b) after treatment of the cells with hydrogen peroxide, which enables detection of alterations of the ROS sensitivity, and (c) by use of formamidopyrimidine DNA-glycosylase (FPG), which provides information on formation of oxidatively damaged bases (pyrimidines). Furthermore, the biochemical parameters TAC (total antioxidant capacity) and oxLDL (oxidized low-density lipoprotein), which reflect the redox status, and C-reactive protein (CRP), a marker of inflammation, were monitored. The intake of the supplement had no significant impact on the DNA stability parameters and on the different biomarkers of the redox status. Our results indicate that intake of 6mg RES per day via the supplement does not cause DNA-protective or antioxidant effects. This amount is equivalent to or lower than that reached after intake of many (ca. 50%) of the RES-containing preparations which are currently on the market in Middle Europe, and is contained in 0.3-2L red wine.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22981768     DOI: 10.1016/j.mrgentox.2012.07.005

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  7 in total

Review 1.  Resveratrol supplementation: Where are we now and where should we go?

Authors:  Marta G Novelle; Devin Wahl; Carlos Diéguez; Michel Bernier; Rafael de Cabo
Journal:  Ageing Res Rev       Date:  2015-01-24       Impact factor: 10.895

2.  A combination of isolated phytochemicals and botanical extracts lowers diastolic blood pressure in a randomized controlled trial of hypertensive subjects.

Authors:  S Biesinger; H A Michaels; A S Quadros; Y Qian; A B Rabovsky; R S Badger; T Jalili
Journal:  Eur J Clin Nutr       Date:  2015-06-10       Impact factor: 4.016

Review 3.  Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

Authors:  Joao Tomé-Carneiro; Mar Larrosa; Antonio González-Sarrías; Francisco A Tomás-Barberán; María Teresa García-Conesa; Juan Carlos Espín
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 4.  Significance of Resveratrol in Clinical Management of Chronic Diseases.

Authors:  Awais Wahab; Kuo Gao; Caixia Jia; Feilong Zhang; Guihua Tian; Ghulam Murtaza; Jianxin Chen
Journal:  Molecules       Date:  2017-08-18       Impact factor: 4.411

Review 5.  Cancer Chemoprevention by Resveratrol: The p53 Tumor Suppressor Protein as a Promising Molecular Target.

Authors:  Danielly C Ferraz da Costa; Eliane Fialho; Jerson L Silva
Journal:  Molecules       Date:  2017-06-18       Impact factor: 4.411

6.  Resveratrol: a supplementation for men or for mice?

Authors:  Valentina Ponzo; Laura Soldati; Simona Bo
Journal:  J Transl Med       Date:  2014-06-03       Impact factor: 5.531

Review 7.  The Potential Use of Resveratrol for Cancer Prevention.

Authors:  Dominique Vervandier-Fasseur; Norbert Latruffe
Journal:  Molecules       Date:  2019-12-09       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.